Journal
EXPERIMENTAL DERMATOLOGY
Volume 25, Issue 2, Pages 157-159Publisher
WILEY
DOI: 10.1111/exd.12863
Keywords
dermal open flow microperfusion; monoclonal antibody; pharmacokinetics; psoriasis; secukinumab
Categories
Funding
- Novartis